|
|
Phase III Randomized Study of Conventional Versus Laparoscopic-Assisted Surgery for Colorectal Cancer
Alternate Title Conventional Surgery Compared With Laparoscopic-Assisted Surgery in Treating Patients With Colorectal Cancer
Objectives
Entry Criteria Disease Characteristics:
Prior/Concurrent Therapy: Biologic therapy:
Chemotherapy:
Endocrine therapy:
Radiotherapy:
Surgery:
Patient Characteristics: Age:
Performance status:
Life expectancy:
Hematopoietic:
Hepatic:
Renal:
Pulmonary:
Other:
Expected Enrollment 1200Approximately 1,200 patients will be accrued for this study within 5 years. Outline This is a randomized, multicenter study. Patients undergo laparoscopic surgery or conventional open surgery. Patients are followed at 1 and 3 months following surgery, then every 3 months for the first year, every 4 months for the second year, and then every 6 months thereafter. Published ResultsGuillou PJ, Quirke P, Thorpe H, et al.: Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 365 (9472): 1718-26, 2005 May 14-20.[PUBMED Abstract] Jayne DG, Brown JM, Thorpe H, et al.: Bladder and sexual function following resection for rectal cancer in a randomized clinical trial of laparoscopic versus open technique. Br J Surg 92 (9): 1124-32, 2005.[PUBMED Abstract] Jayne DG, Guillou PJ, Thorpe H, et al.: Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol 25 (21): 3061-8, 2007.[PUBMED Abstract] Trial Lead Organizations Medical Research Council Clinical Trials Unit
Note: The purpose of most clinical trials listed in this database is to test new cancer treatments, or new methods of diagnosing, screening, or preventing cancer. Because all potentially harmful side effects are not known before a trial is conducted, dose and schedule modifications may be required for participants if they develop side effects from the treatment or test. The therapy or test described in this clinical trial is intended for use by clinical oncologists in carefully structured settings, and may not prove to be more effective than standard treatment. A responsible investigator associated with this clinical trial should be consulted before using this protocol. Back to Top |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NCI Home |
Text-Only Version |
Contact Us |
Policies |
Accessibility |
RSS |
Viewing Files |
FOIA |
Site Help |
Site Map
|
A Service of the National Cancer Institute |